Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 19, 2013
Innovative bare metal stent designed to treat Peripheral Artery Disease.
-
Aug 13, 2013
Public offering consists of $600 million of 2.650% notes due October 1, 2018 and $450 million of 4.125% notes due October 1, 2023.
-
Aug 8, 2013
Company expects to receive the net offering proceeds upon closing on August 13, 2013, subject to customary closing conditions.
-
Jul 25, 2013
"As we continue to expand our portfolio, our team is inspired to deliver meaningful innovation to more patients globally," said president and CEO Mike Mahoney.
-
Jul 24, 2013
System is next-generation 3D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology (EP) procedures.
-
Jul 24, 2013
Next generation intravascular ultrasound catheter improves image quality and deliverability
-
Jul 19, 2013
First patient treated in OPTIMISE clinical trial evaluating safety, efficacy of occipital nerve stimulation using Precision™ system.
-
Jul 12, 2013
Device facilitates delivery of interventional devices in complex PCI procedures.
-
Jul 11, 2013
Boston Scientific will webcast its conference call with financial results and business highlights for Q2 ended June 30, 2013. Learn how to tune in.
-
Jun 28, 2013
Transaction to accelerate Boston Scientific expansion in growing electrophysiology market